Horiba Medical
| |
HORIBA Medical | |
Formerly called | HORIBA ABX SAS |
Fate | Acquired (in 1996) |
Founded | Montpellier, France (1983 ) |
Products | In vitro diagnostic instruments |
Parent | Horiba |
The HORIBA Group, headquartered in Japan, was founded in Kyoto in 1945 by Masao Horiba. The company is divided in five different segments: automotive, process & environmental, semi-conductor, scientific and medical. The Group is producing for public and private sectors, from fundamental research to industrial development and production via the management of environmental impact.
The HORIBA Medical segment, formerly known as ABX Company, is specialized as designer and manufacturer of medical instruments and reagents for in vitro diagnostics industry.
HORIBA Group
Sectors
HORIBA is a group involved in measurement technology for more than 50 years now. The HORIBA Group is diversified in 5 different sectors: automotive, environmental, medical, semiconductor and scientific fields.
Key figures
The head office of the parent company is located at 2 Miyanohigashi, Kisshoin, Minami-ku, Kyoto, 601-8510, Japan. This Group was founded the 17th of October 1945, his capital is about 12.0 billion yen and his fiscal closing date is on December 31. The CEO is Atsushi Horiba[1] and 5787 employees are managed throughout 38 companies.
Localization
The HORIBA Group is internationally present and produces over the five continents.
HORIBA Medical
Key figures
HORIBA Medical annually produces 7,500 instruments and 10,000 tons of reagents. There are over 1,000 employees across the different sites.[2] This segment is composed of 5 production centers, 2 R&D centers. There are 100 distributors, 14 direct/local operations and around 30,000 laboratories supplied worldwide and sales of €207 million in 2013.[3]
Products
The HORIBA Medical Segment designs, develops and distributes worldwide in vitro diagnostic systems mainly destined for biological analysis in a medical laboratory. These automated analyzers are designed for various users including patients, doctors, private laboratories, clinics and university hospitals.
Nowadays, the company has widened its range via two new sectors: clinical chemistry and point-of-care testing.
Hematology Analyzers & Peripherals
- Pentra DX Nexus
- Pentra DF Nexus
- ABX Pentra DF & DX 120 (5 DIFF)
- Pentra XLR
- ABX Pentra 80 & XL 80 (5 DIFF)
- Micros Emi CRP
- ABX Pentra 60 & 60C+ (5 DIFF)
- ABX Micros 60, ES 60, ABC Vet, CRP 200. (3 DIFF)
- ABX SPS Module
- ABX Pentra ML
- ABX e-Sat
Sat 5000
Clinical chemistry Analyzers
References
- ↑
- Dr.Jai Hakhu nommé nouveau président héraultjuridique.com
- ↑
- "Nouvelle architecture de sauvegarde" SolutioniIT PME Magazine
- ↑
- "Nouvelle architecture de sauvegarde" SolutioniIT PME Magazine
- "HORIBA : un retour aux sources" Media Paris-Sarclay
- "Nouvelle architecture de sauvegarde" SolutioniIT PME Magazine
- HORIBA et les technologies de l'information INSEE
- Atsushi Horiba Agence Française pour les investissements internationaux
- Dr.Jai Hakhu nommé nouveau président héraultjuridique.com
- Issues stories "HORIBA ABX.Inc Clinical Labs Products magazine
- Fiche de l’entreprise Verif.com
- Nouvelle usine www.nouvelleusine.com
External links
HORIBA Corporate
HORIBA Medical